000 02504 a2200805 4500
005 20250517152336.0
264 0 _c20170822
008 201708s 0 0 eng d
022 _a1532-1827
024 7 _a10.1038/bjc.2017.122
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCustodio, A
245 0 0 _aNomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab.
_h[electronic resource]
260 _bBritish journal of cancer
_cJun 2017
300 _a1526-1535 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Validation Study
650 0 4 _aAdenocarcinoma
_xchemistry
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aAscites
_xetiology
650 0 4 _aBone Neoplasms
_xsecondary
650 0 4 _aEsophageal Neoplasms
_xchemistry
650 0 4 _aEsophagogastric Junction
650 0 4 _aHealth Status
650 0 4 _aHumans
650 0 4 _aLymphocyte Count
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Grading
650 0 4 _aNeutrophils
650 0 4 _aNomograms
650 0 4 _aReceptor, ErbB-2
_xanalysis
650 0 4 _aStomach Neoplasms
_xchemistry
650 0 4 _aSurvival Rate
650 0 4 _aTrastuzumab
_xadministration & dosage
650 0 4 _aTumor Burden
650 0 4 _aWhite People
650 0 4 _aYoung Adult
700 1 _aCarmona-Bayonas, A
700 1 _aJiménez-Fonseca, P
700 1 _aSánchez, M L
700 1 _aViudez, A
700 1 _aHernández, R
700 1 _aCano, J M
700 1 _aEchavarria, I
700 1 _aPericay, C
700 1 _aMangas, M
700 1 _aVisa, L
700 1 _aBuxo, E
700 1 _aGarcía, T
700 1 _aRodríguez Palomo, A
700 1 _aÁlvarez Manceñido, F
700 1 _aLacalle, A
700 1 _aMacias, I
700 1 _aAzkarate, A
700 1 _aRamchandani, A
700 1 _aFernández Montes, A
700 1 _aLópez, C
700 1 _aLongo, F
700 1 _aSánchez Bayona, R
700 1 _aLimón, M L
700 1 _aDíaz-Serrano, A
700 1 _aHurtado, A
700 1 _aMadero, R
700 1 _aGómez, C
700 1 _aGallego, J
773 0 _tBritish journal of cancer
_gvol. 116
_gno. 12
_gp. 1526-1535
856 4 0 _uhttps://doi.org/10.1038/bjc.2017.122
_zAvailable from publisher's website
999 _c27133961
_d27133961